Traduction de «traitement à doses multiples » (Français → Anglais) :

For carers and comforters and for volunteers participating in medical and biomedical research (for whom no direct medical benefit is expected from the exposure), dose constraints shall be established in terms of the individual dose that is unlikely to be exceeded for the period of the examination, treatment or research project in question.

Competent authorities shall evaluate dose response data generated in trials (which must include an untreated control) involving dose rates lower than the recommended rate, in order to assess if the recommended dose is the minimum necessary to achieve the desired effect.

Competent authorities shall evaluate dose response data generated in trials (which must include an untreated control) involving dose rates lower than the recommended rate, in order to assess if the recommended dose is the minimum necessary to achieve the desired effect.

In view of the recommendations from the European Commission report of 2007 'Tackling Multiple Discrimination - Practices, Policies and Laws', that multiple discrimination should be expressly prohibited, why is there no express prohibition on multiple discrimination in the draft Equality Directive (COM(2008)0426), and only one reference to multiple discrimination (in the context of women) in the preamble (i.e. No 13)?

The studies presented address the question of impact of treatment from a number of standpoints:

The paper also makes a useful summary of the state of knowledge in the key areas. The following is a list of areas considered by the group as worthy of research : - research aimed at establishing whether or not BSE has been transmitted to man; - working on the hypothesis that BSE may be transmissible to man, a number of suggestions are put forward aimed at establishing a risk assessment such as work on determining whether multiple dosing is cumulative and an estimation of the utilisation of offal in different human food products prior to the ban and the consumption of those products by individual age groups and socio-economic criteria; ...[+++] - is there infectivity in BSE-infected cattle derived products other than SBO (Specified Bovine Offal) ?; - further research to establish the precise reason or route for maternal transmission of BSE in some cases; - establish if it is possible that BSE originated as a (rare) spontaneous event in cattle and that the BSE agent is different from the scrapie agent; - can BSE be transmitted orally to pigs ?; - research into the development of diagnostic techniques for BSE and CJD; - establish the efficiency of BSE inactivation procedures used in the food and pharmaceutical industry; - certain areas are suggested for research into developing therapeutic treatment for victims of the CJD disease and also into developing a test which would indicate those people susceptible to the disease; - predictive research is also proposed as it has been shown that CJD occurs rarely in individuals with certain genes.